Makeen Hafiz A, Buraik Mohammed A, Menachery Santhosh Joseph, Alattas Khalid M, Meraya Abdulkarim M
Department of Clinical Pharmacy, Faculty of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Departments of Dermatology and Pathology, King Fahd Central Hospital, Jazan, Saudi Arabia.
Ann Dermatol. 2018 Oct;30(5):575-580. doi: 10.5021/ad.2018.30.5.575. Epub 2018 Aug 28.
Cutaneous leishmaniasis is a tropical infection of public health importance. Numerous treatment approaches are in practice with variable degree of success however its management has no universal consensus or practice guidelines to follow.
Analyze the management of cutaneous leishmaniasis retrospectively at a central hospital of Jazan Province, Kingdom of Saudi Arabia to identify the current treatment pattern and compare the outcomes.
This cross-sectional study was conducted based on the hospital records of patients who attended the dermatology clinic for cutaneous leishmaniasis during the year 2012 to 2015.
Forty three patients were included in the study. There was a male preponderance (65.1%) among the patients and 60.5% of them were of pediatric age group. Monotherapy was the initial choice for 58.1% of the patients. Intralesional sodium stibogluconate (SS-IL) was the most preferred treatment for initial therapy, as monotherapy and as part of combination therapy. A complete response was achieved in 22 patients (51.2%) with initial therapy. Among the different treatment groups, SS-IL+itraconazole showed significantly higher complete response rate compared to other treatments offered as initial therapy (<0.01). Initial SS-IL monotherapy provided complete response in 41.2% patients receiving it, while itraconazole monotherapy provided complete response in 75% and 90.9% of the patients receiving initial itraconazole+SS-IL combination therapy with achieved complete response.
The findings and observations suggest that initial combination therapy with SS-IL+itraconazole significantly improved the complete response rates and thus reduced the need for additional or prolonged therapies.
皮肤利什曼病是一种具有公共卫生重要性的热带感染病。目前有多种治疗方法在实践中应用,但其成功率各不相同,而且在该病的管理方面尚无普遍共识或遵循的实践指南。
回顾性分析沙特阿拉伯王国吉赞省一家中心医院对皮肤利什曼病的管理情况,以确定当前的治疗模式并比较治疗结果。
本横断面研究基于2012年至2015年期间到皮肤科门诊就诊的皮肤利什曼病患者的医院记录进行。
43名患者纳入研究。患者中男性占多数(65.1%),其中60.5%为儿童年龄组。58.1%的患者最初选择单一疗法。病灶内注射葡萄糖酸锑钠(SS-IL)是初始治疗、单一疗法以及联合疗法中最常用的治疗方法。初始治疗中有22名患者(51.2%)获得完全缓解。在不同治疗组中,与其他作为初始治疗的方法相比,SS-IL+伊曲康唑的完全缓解率显著更高(<0.01)。接受初始SS-IL单一疗法的患者中有41.2%获得完全缓解,而接受初始伊曲康唑+SS-IL联合疗法且获得完全缓解的患者中,伊曲康唑单一疗法分别使75%和90.9%的患者获得完全缓解。
研究结果表明,SS-IL+伊曲康唑初始联合疗法显著提高了完全缓解率,从而减少了额外或延长治疗的需求。